
“Uncovering the Truth: Investigating Akero Therapeutics Inc. (AKRO) with Bronstein Gewirtz and Gonzalez”
Investigating Potential Claims on Akero Therapeutics, Inc. February 9, 2025 Recently, Bronstein, Gewirtz & Grossman, LLC announced that they are investigating potential claims on behalf of purchasers of Akero Therapeutics, Inc. (“Akero” or “the Company”) (NASDAQ:AKRO). This news has stirred up the investment community, leaving many shareholders concerned about the future of their investments. If…